Determination of bezafibrate, ciprofibrate and fenofibric acid in human plasma by high-performance liquid chromatography

Journal of Chromatography B: Biomedical Applications

Volumn 687, Issue 2, 1996, Pages 437-442

  Masnatta, Lucas Daniel ^a   Cuniberti, Luis Alberto ^a   Rey, Ricardo Horacio ^a   Werba, José Pablo ^a  

^a FAVALORO UNIVERSITY   (Argentina)

Author keywords

Bezafibrate; Ciprofibrate; Fenofibric acid; Fibrate monitoring

Indexed keywords

BEZAFIBRATE; CIPROFIBRATE; FENOFIBRIC ACID;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANTILIPEMIC AGENTS; BEZAFIBRATE; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLOFIBRIC ACID; HUMANS; PROCETOFEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0030582748     PISSN: 15726495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(96)00254-X     Document Type: Article

References (10)

1. [1] M. Lytken Larsen and D.R. Illingworth, Curr. Opin. Lipidol., 4 (1992) 34-40.
2. [2] R. Illingworth, in B.M. Rifkind (Editor), Drug Treatment of Hyperlipidemia, Marcel Dekker, New York, 1991, pp. 103-138.
3. [3] J.R. Evans, S.C. Forland and R.E. Cutler, J. Clin. Pharmacol., 27 (1987) 994-1000.
4. [4] A.J. Williams, F. Baker and J. Walls, Br. J. Clin. Pharmacol., 18 (1984) 361-367.
5. [5] N. Ferry, N. Bernard, N. Pozet, E. Gardes, G. Cuisinaud, M Labeeuw, P.Y. Zech and J. Sassard, Br. J. Pharmacol., 28 (1989) 675-681.
6. [6] J.A. Balfour, D. McTavish and R.C. Heel, Drugs, 40 (1990) 260-290.
7. [7] D. Castoldi, V. Monzani and O. Tofanetti, J. Chromatogr., 344 (1985) 259-265.
8. [8] G.B. Park, C.E. Biddlecome, C. Koblantz and J. Edelson, J. Chromatogr., 227 (1982) 534-539.
9. [9] A.C. Ramusino and A. Carozzi, J. Chromatogr., 383 (1986) 419-424.
10. [10] D.J. Anderson, Clin. Chem., 35 (1989) 2152-3.